<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate whether anticardiolipin (aCL) and anti-beta(2)-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (anti-beta(2)GPI) antibodies are associated with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> (group II patients), and whether there are differences in the prevalence of these two autoantibodies between group II patients and patients with non-<z:hpo ids='HP_0000123'>nephritis</z:hpo> SLE (group I) and <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (PAPS) patients (group III) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: IgG and IgM aCL were measured in 31 patients and anti-beta(2)GPI in 30 patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) <z:hpo ids='HP_0000123'>nephritis</z:hpo> and 25 without SLE <z:hpo ids='HP_0000123'>nephritis</z:hpo> and in 36 PAPS patients by validated enzyme immunoassays </plain></SENT>
<SENT sid="2" pm="."><plain>Relationships of anti-<z:chebi fb="0" ids="4705">double-stranded DNA</z:chebi> (anti-dsDNA) antibodies and antibodies to the collagenous region of C1q (anti-C1q) with SLE <z:hpo ids='HP_0000123'>nephritis</z:hpo> were also examined </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The prevalence and levels were higher for aCL, but not for anti-beta(2)GPI, antibodies in group II than in group I patients </plain></SENT>
<SENT sid="4" pm="."><plain>Absolute values of aCL and anti-beta(2)GPI in <z:hpo ids='HP_0000001'>all</z:hpo> three patient groups correlated with each other </plain></SENT>
<SENT sid="5" pm="."><plain>The prevalences of aCL, anti-dsDNA and anti-C1q antibodies were significantly higher in group II than in group I and group III patients </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: The observations in this paper suggest that raised levels of aCL antibodies are associated with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>We were not able to demonstrate an association between anti-beta(2)GPI antibodies and <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> either in patients with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> or in patients with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>In SLE, we demonstrated that the presence of anticardiolipin antibodies in conjunction with elevated levels of anti-dsDNA and anti-C1q antibodies is highly specific for <z:hpo ids='HP_0000099'>glomerulonephritis</z:hpo> in patients with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> </plain></SENT>
</text></document>